CTOs on the Move

The Mighty

www.themighty.com

 
The Mighty is a digital health community created to empower and connect people facing health challenges and disabilities. We have over 2.5 million registered users and are adding a new one every 20 seconds. Our stories and videos are viewed and shared more than 90 million times a month. But those are just stats. This experience from a community member is what we`re really after: “How is it that I read an essay on The Mighty and it is the only place in the world where I feel truly understood? Time and time again you speak to me through your ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.themighty.com
  • 210 N Glenoaks Boulevard Suite C
    Burbank, CA USA 91502
  • Phone: 213.379.2407

Executives

Name Title Contact Details
Peter Wang
Chief Technology Officer Profile

Similar Companies

Bold Air Respiratory Inc

Bold Air Respiratory Inc is a Brick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASK Childhood Cancer Foundation

ASK Childhood Cancer Foundation is a nonprofit organization that provides assistance, support, and kindness to families whose children are being treated for cancer in Central Virginia.

American Sports Medicine Institute

American Sports Medicine Institute is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encompass Health System

Encompass Health System is a West Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.